Orakl Oncology

Je #recrute (#hiring). Connaissez-vous quelqu’un qui pourrait être intéressé ? 👋😊

Come and join us! 🤩 Fantastic internship opportunities, do not hesitate to share with your networks!

Orakl Oncology will be present at #ESMO2024 from September 13 to 17th in Barcelona. 🎙️ Our CEO, Fanny Jaulin, PhD, is an invited speaker and will talking about organoids and personalized oncology. 🧫 In parrallel, we'll be presenting our latest results on the use of patient avatars in precision oncology. Interested to learn more? Reach out to our team (cc Diane-Laure Pagès and Fanny Jaulin, PhD) or write to [email protected] Gizem Altay Anna-Rose Gryspeert Gustave Ronteix

Happy World Music Day everyone 🎶🧫 Credits: DALL•E 🙃

Orakl Oncology is on the floor at HLTH Europe! Fanny Jaulin, PhD, Gustave Ronteix, Diane-Laure Pagès - Gustave Ronteix, co-founder & CTO, on the "Out of the lab and into a tab: get ready to the in silico boom" session, moderated by Samantha J. from Elaia, with Hadas Bitran Partner GM Health AI Microsoft and Rabea Knorr, Head of Department Industrial Health at the Federation of German Industries Great talks about the stakes and challenges of the use of data and AI in health and drug development - access to data is still a challenge and this is key, as highlighted by Rabea Knorr! "Then you really need to be able to prove the clinical relevance of the insights your model is providing", said Gustave Ronteix - Fanny Jaulin, PhD, co-founder & CEO, pitching at the Startup Finals tomorrow morning! Come meet us at our booth B166 🎉

📣 There's been so much happening in AI recently that the good old wet lab work sometimes looks a bit out of date. But really, the need for ever more data to crunch actually puts the lab at the center. To discuss this further, I'm very happy to be representing Orakl Oncology at HLTH Europe on a panel titled “Out of the lab and onto a tab: Get ready for the in silico boom” with a stellar panel. If you're passionate about oncology, drug discovery or combining wetlab and drylab work feel free to reach out! Join us in Amsterdam with Fanny Jaulin, PhD and Diane-Laure Pagès on June 18th 2024 from 9:50 AM to 10:30 AM on the Touch Stage. Panellists: Jack O'Meara, Co-founder and CEO, Ochre Bio Hadas Bitran, Partner GM, Health AI, Microsoft Rabea Knorr, Head of Department Industrial Health, Federation of German Industries (BDI) Moderator: Samantha J., Partner, Elaia #hlth #hltheurope #digitalhealth #healthcare #healthtech

“Out of the lab and onto a tab: Get ready for the in silico boom”! 📣 We are thrilled to announce that Gustave Ronteix will be the speaker for Orakl Oncology at HLTH Europe “Out of the lab and onto a tab: Get ready for the in silico boom” session (sponsored by Novo Nordisk) . Join us in Amsterdam on June 18th 2024 from 9:50 AM to 10:30 AM at Touch Stage to witness this inspiring and exciting exchange. Panellists:  Gustave Ronteix, Co-Founder & CTO, Orakl Oncology Jack O'Meara, Co-founder and CEO, Ochre Bio Hadas Bitran, Partner GM, Health AI, Microsoft Rabea Knorr, Head of Department Industrial Health, Federation of German Industries (BDI) Moderator: Samantha J., Partner, Elaia We look forward to taking the stage and meeting you at our booth as well! 🙏 Thanks a lot to HLTH Europe for the invitation, we are honoured to participate to this beautifull roundtable. #hlth #hltheurope #digitalhealth #healthcare #healthtech

🎤 Startups, scale-ups, monde hospitalier, corps soignant, industriels pharmaceutiques, ... participez jusqu'au 31 juin au questionnaire et contribuez au livre blanc "Organoïdes, organes et données de santé" lancé par Orakl Oncology BioValley France @Hôtel-Dieu, BioLabs France Hôtel-Dieu, à paraître ce 18/09 à l'Agora du soin ! 👉 Hôpitaux / corps soignant / patients & assos de patients : https://lnkd.in/eGhFaHVE 👉 Startups/scale-ups : https://lnkd.in/evhATqnG 👉 Industrie pharmaceutique : https://lnkd.in/eX6YZWWG 🎯 L'initiative, en complément des travaux en cours (nb: Comité Stratégique de Filière organoïdes et organes sur puces) s'attachera à explorer les potentiels et enjeux des organoïdes et organes (exemple du projet Liver InMachina) et formuler les recommandations pratiques pour des données de santé au service de la recherche et développement de nouveaux traitements. Notamment en oncologie, en maladies hépathobilaires oncologiques, et au-delà ! 💡 Nous avons hâte de découvrir vos retours (nominatifs ou anonymes) ! Et en complément de ce questionnaire, nous réaliserons à l'été une série d'interviews ciblées auprès de nos partenaires, de nos résidents en pointe sur le domaine, et de l'ensemble représentatif de l'écosystème du soin. Et ainsi, formaliser collectivement les recommandations et actions concrètes pour une filière performante à la hauteur des enjeux patients ! CC Fanny Jaulin, PhD Gustave Ronteix Diane-Laure Pagès Jean-Dominique Guitton Elie Farha, MD Thibault Honegger Julian Rozenberg Nicolas Castoldi Nina Rognon Christophe Tallec

We are thrilled to announce that we will be pitching at 2024 BIO International Convention! San Diego, California, June 3-6.  We are grateful to BIO for selecting us as one of the finalists of the Start-Up Stadium Pitch Session. Fanny Jaulin, PhD will present Orakl on Tuesday, June 4 from 11:00 AM to 01:00 PM. At Orakl Oncology, we are at the forefront of innovation and research in oncology, combining patient biology and data with AI into tumor avatars to accelerate drug discovery and ensure translatability of drug development. Join us and meet Fanny Jaulin, PhD & Diane-Laure Pagès at BIO at the French Pavilion. We are excited to present our latest advances and to create partnership opportunities! Business France Healthcare - North America #ChooseFrance, Business France

Something big was happening there! Amaized to all these very small and very big (but all vibrant!), companies interacting at Vivatech!